Drug
Who makes ivabradine?
11 companies list ivabradine as a human prescription drug, including under the names Corlanor. Forms: solution; tablet; tablet, film coated. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing ivabradine
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Alembic Pharmaceuticals LimitedIndia | tablet, film coated | ANDAANDA215238 | 4 | 7 |
| Amgen, IncUnited States | solution; tablet, film coated | NDANDA206143, NDA209964 | 3 | 9 |
| Zydus Lifesciences LimitedIndia | tablet | ANDAANDA213442 | 2 | 12 |
| Bionpharma Inc.India | tablet, film coated | ANDAANDA213276 | 2 | 1 |
| Camber Pharmaceuticals, Inc.United States | tablet, film coated | ANDAANDA213366 | 2 | 1 |
| Golden State Medical Supply Inc.United States | tablet, film coated | ANDAANDA214051 | 2 | 1 |
| Zydus Pharmaceuticals USA Inc.India | tablet | ANDAANDA213442 | 2 | 1 |
| Ingenus Pharmaceuticals, LLC | tablet, film coated | ANDAANDA214051 | 2 | 0 |
| Northstar Rx, LLC, | tablet, film coated | ANDAANDA213483 | 2 | 0 |
| Novadoz Pharmaceuticals LLC | tablet, film coated | ANDAANDA213483 | 2 | 0 |
| Pharma Packaging Solutions, LLC dba Tjoapack, LLCUnited States | tablet, film coated | ANDAANDA213366 | 1 | 5 |
Orange Book patents
1 unexpired patent lists ivabradine as the active ingredient, expiring between Dec 2026 and Dec 2026. Application holder: AMGEN INC.
Enquiry
Common questions
- Who makes ivabradine?
- 11 companies list ivabradine as a human prescription drug in the openFDA NDC Directory, led by Alembic Pharmaceuticals Limited, Amgen, Inc, Zydus Lifesciences Limited, Bionpharma Inc., Camber Pharmaceuticals, Inc.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic Corlanor?
- 10 companies list ivabradine under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.